RISW2025
Back to all people

Xiaolong Luo

Sarepta Therapeutics
1 appearance in the program

Sessions & presentations

PS49: Advancing Rare Disease Drug Development with Totality of Evidence
Presentation: Multiple Comparisons Procedures for Analyses of Joint Primary Endpoints and Secondary Endpoints
Parallel · Fri, Sep 26 , 2:50 PM
Presenting Author
↑